Join the Dravet Syndrome group to help and get support from people like you.
Dravet Syndrome News
Related terms: Severe Myoclonic Epilepsy of Infancy, SMEI
Antiseizure Drug Diacomit Now Approved for Children as Young as 6 Months
SAN MATEO, Calif., Sept. 21, 2022 /PRNewswire/ – Biocodex, Inc., a pharmaceutical company and manufacturer of Diacomit® (stiripentol), announced today that the U.S. Food and Drug Administration (...
FDA Approves Fintepla (fenfluramine) for the Treatment of Seizures Associated with Dravet Syndrome
EMERYVILLE, Calif., June 25, 2020 (GLOBE NEWSWIRE) – Zogenix, Inc. (NASDAQ: ZGNX), a global pharmaceutical company developing rare disease therapies, today announced that the U.S. Food and Drug...
FDA Approves Diacomit (stiripentol) for Seizures Associated with Dravet Syndrome
On August 20, 2018, the U.S. Food and Drug Administration (FDA) approved Diacomit (stiripentol) for seizures associated with Dravet syndrome in patients 2 years of age and older taking clobazam. ...
FDA Approves Diacomit (stiripentol) for Seizures Associated with Dravet Syndrome
On August 20, 2018, the U.S. Food and Drug Administration (FDA) approved Diacomit (stiripentol) for seizures associated with Dravet syndrome in patients 2 years of age and older taking clobazam. ...
FDA Approves Epidiolex (cannabidiol) to Treat Lennox-Gastaut Syndrome and Dravet Syndrome
June 25, 2018 – The U.S. Food and Drug Administration today approved Epidiolex (cannabidiol) [CBD] oral solution for the treatment of seizures associated with two rare and severe forms of epilepsy,...
Ask a question
To post your own question to this support group, sign in or create an account.